학술논문
Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE): interim analysis of a randomised, controlled, phase 3, immunobridging trial
Document Type
Article
Author
Bethune, Claire; Boffito, Marta; Bula, Marcin; Burns, Fiona M; Clark, Rebecca; Dasyam, Dileep; Drysdale, Simon; Faust, Saul; Gkrania-Klotsas, Effrossyni; Green, Christopher; Hassanin, Hana; Heath, Paul; Heer, Amardeep; Helliwell, Toby; Hormis, Anil; Kalra, Philip; Lazarus, Rajeka; Moran, Ed; Ndikum, John; Page, Iain; Price, David; Probert, Nick; Ramjee, Mahadev; Rampling, Tommy; Randeva, Harpal S; Ryder, Stephen; Steer, John; Thompson, Emma; Torku, David; Querton, Benedicte; Corbic Ramljak, Irena; Dewasthaly, Shailesh; Jaramillo, Juan Carlos; Dubischar, Katrin; Krammer, Michael; Weisova, Petronela; Hochreiter, Romana; Eder-Lingelbach, Susanne; Taucher, Christian ; Finn, Adam
Source
In The Lancet Infectious Diseases December 2022 22(12):1716-1727
Subject
Language
ISSN
1473-3099